Global Hemato Oncology Testing Market, By Service & Product (Services and Assay Kits), By Cancer Type (Leukemia (Acute myeloid leukaemia, Acute lymphocytic leukaemia and Other leukaemia (Chronic lymphocytic leukaemia, and chronic myeloid leukaemia)), Lymphoma (Non-Hodgkin’s Lymphoma, Hodgkin’s Lymphoma and Other Cancers (Myeloma, Myelofibrosis (MF), Essential Thrombocythemia)), By Technology (PCR, IHC, NGS, Cytogenetics, and Others), By End User (Clinical laboratories, Hospitals, Academic & Research Institutes and Other End Users (CROs and Pharmaceutical & Biotechnology Companies), and By Region (North America, Latin America, Asia Pacific, Europe, and Africa & the Middle East) - Global Forecast to 2029

Report Code: PMI453220 | Publish Date: May 2023 | No. of Pages: 142

Global Hemato Oncology Testing Market Overview

Haematology-oncology testing is the identification, precaution and treatment of cancer (oncology) and blood disease (haematology), followed by research into them. Hematology-oncology contains disorders such as iron deficiency anaemia, sickle cell disease, haemophilia, leukaemias, thalassemia’s and lymphomas, as well as cancers of other organs. Growth is guided by the increasing worldwide prevalence of hematologic cancer, exponential awareness concerning customized medications, and expanding alliances for maturing new tests.

Global Hemato Oncology Testing Market Dynamics

Growth in the prevalence of Lymphoma & Myeloma Cancers

After non-Hodgkin’s Lymphoma and leukaemia, Multiple myeloma is categorized as the 3rd most standard configuration of haematological malignancy. Within the bone marrow, it is differentiated by rapid propagation of a duplicate plasma cells. Concerning the study carried out at Leukemia & Lymphoma Society (LLS), approximately 176,200 people in the United States are thought to be diagnosed with myeloma, Lymphoma and leukaemia in 2019. New cases are predicted to record for 10% of the reckoned 1,762,450 new cancer cases tested in the U.S. in 2019. Prevalence is the rough count of people lives on a particular date in a populace who have been diagnosed by the disease. An approximate 1,399,180 people in the U.S. are either alive with or are recovering from, leukaemia, Lymphoma, or myeloma. 

Increasing focus on personalized medicine

The ideas of Personalized Medicines have been valued in medicine with its 1st mention in a title in 1998 and followed by publication on the Medline interface in 1999. Evolution in genetic technologies, like single nucleotide polymorphism (SNP), genotyping and microarray/biochips have been the main and the driving strategy.

However, technical and clinical-related challenges might hamper the growth of the global market to a certain extent.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Hemato Oncology Testing Market Segmentation

The global hemato oncology testing market is segmented by product & service, cancer type, technology, end user, and region.

Based on the product, the global hemato oncology testing market is segmented into assay kits and services. Based on the cancer leukemia, the target market is classified into leukemia (acute myeloid leukaemia, acute lymphocytic leukaemia, and other leukaemia (chronic lymphocytic leukaemia and, chronic myeloid leukaemia)), lymphoma (Non-Hodgkin’s lymphoma, Hodgkin’s lymphoma, and other cancers (myeloma, myelofibrosis (mf), essential thrombocythemia). Based on the technology, the global market is segmented into PCR, IHC, NGS, cytogenetics, and others. Based on the end-user, it is segmented into CROs and, pharmaceutical & biotechnology companies.

Regional Insights:

According to the region, market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific is estimated to record the most considerable CAGR in the market during the prediction period. Whereas, the North America dominated the market in 2018. Increase in the APAC market is operated mostly by the massive population of the patient, and increment in focusing the critical players on expansion in this region will drive the growth of the market. Moreover, the Asia Pacific will register the enormous growth rate during the prediction period (2019–2024)”

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Report Scope:

Attribute

Details

The base year for estimation

2018

Forecast period

2019 – 2029

Market representation

Revenue in USD Million & CAGR from 2019 – 2024

Market Segmentation

By Product & Services – Services and Assay Kits

By Cancer Type – Leukaemia (Acute myeloid leukaemia, Acute lymphocytic leukaemia, and Other leukaemia (Chronic lymphocytic leukaemia and Chronic Myeloid Leukaemia)) and

Lymphoma (Non-Hodgkin’s Lymphoma, Hodgkin’s Lymphoma, and Other cancers (Myeloma, Myelofibrosis (MF), Essential Thrombocythemia))

By Technology- PCR, IHC, NGS, Cytogenetics, and Others

By End User- Clinical laboratories, Hospitals, Academic & Research Institutes, and Other End Users (CROs and Pharmaceutical & Biotechnology Companies).

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends.

 

Segments Covered in the Report:

This report represents the revenue growth at regional, country and global levels and serves an interpretation of the most recent industry trends and opportunities in every sub- segments from 2019 to 2024. For this study, has segmented the global hemato oncology testing market by product & services, cancer leukemia, technology, end-user & region.

Global Hemato Oncology Testing Market, by product & services:

  • Services
  • Assay Kits

Global Hemato Oncology Testing Market, by Cancer Type:

  • Leukaemia
  • Acute myeloid leukaemia
  • Acute lymphocytic leukaemia
  •  Other leukaemia (Chronic lymphocytic leukaemia and chronic myeloid leukaemia)
  • Lymphoma
  • Non-Hodgkin’s Lymphoma
  • Hodgkin’s Lymphoma
  • Other cancers (Myeloma, Myelofibrosis (MF))
  • Essential Thrombocythemia

Global Hemato Oncology Testing Market, by Technology:

  • PCR
  • IHC
  • NGS
  • Cytogenetics
  • Others

Global Hemato Oncology Testing Market, by End User:

  • Clinical laboratories,
  • Hospitals, Academic
  • Research Institutes,
  • Other End Users (CROs, Pharmaceutical & Biotechnology Companies).

Global Hemato Oncology Testing Market, By Region:

      • North America
          • U.S.
          • Canada
      • Europe
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Rest of Europe
      • Asia Pacific
          • China
          • India
          • Japan
          • South Korea
          • Rest of Asia Pacific
      • Latin America
          • Brazil
          • Mexico
          • Rest of Latin America
      • Middle East & Africa
          • GCC
          • Israel
          • South Africa
          • Rest of Middle East & Africa

Global Hemato Oncology Testing Market Key Players

The key players operating in the global hemato oncology testing market include F. Hoffmann-La Roche Ltd. , Abbott Laboratories , Thermo Fisher Scientific, Inc. , QIAGEN N.V., Bio-Rad Laboratories, Inc. , Illumina, Inc. , MolecularMD (Ireland), Invivoscribe, Inc. , Asuragen, Inc. , Adaptive Biotechnologies . Companies are forming alliances to improve the product portfolio and market presence. For instance, In May 2018, Adaptive Biotechnologies (US) collaborated with Sanofi, SA. (US), to utilize Adaptive’s clonoSEQ Assay to measure MRD status in response to isatuximab.

Global Hemato Oncology Testing Market Company Profile

    • F. Hoffmann-La Roche Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Business Strategies
    • Abbott Laboratories 
    • Thermo Fisher Scientific, Inc.
    •  QIAGEN N.V.
    • Bio-Rad Laboratories, Inc.
    • Illumina, Inc.
    • MolecularMD
    • Invivoscribe, Inc.
    • Asuragen, Inc.
    • Adaptive Biotechnologies

Global Hemato Oncology Testing Market Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for Breathable Membranes Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Service & Product
      • Market Snippet, By Cancer Type
      • Market Snippet, By Technology
      • Market Snippet, By End User 
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Global Hemato Oncology Testing Market, By Service & Product, 2019 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
    • Services, [L1] 
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
  • Assay Kits
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
  1. Global Hemato Oncology Testing Market, By Cancer Type, 2019 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
    • Leukemia
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
    • Lymphoma
      • llsOverview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
  2. Global Hemato Oncology Testing Market, By Technology, 2019 – 2029, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
  • PCR
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
  • IHC
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
  • NGS
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
  • Cytogenetics, 
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
  • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029

8. Global Hemato Oncology Testing Market, By Technology, 2019 – 2029, (US$ Mn)

    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Segment Trends
  • Clinical laboratories,
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
  • Hospitals, Academic & Research Institutes,
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
  • Other End Users
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029

9. Global Hemato Oncology Testing Market By Region, 2019 – 2029, (US$ Mn)

    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
      • Y-o-Y Growth Analysis (%), 2019 – 2029
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Service & Product, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Cancer Type, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Technology, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Service & Product, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Cancer Type, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Technology, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Service & Product, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Cancer Type, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Technology, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
        • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Service & Product, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Cancer Type, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Technology, 2019 – 2029
      • Market Size  and Forecast (US$ Mn), By Country, 2019 – 2029
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Mn), By Service & Product, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Cancer Type, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Technology, 2019 – 2029
      • Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  2. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  3. Company Profiles
  • Hoffmann-La Roche Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Business Strategies
    • Abbott Laboratories 
    • Thermo Fisher Scientific, Inc.
    •  QIAGEN N.V.
    • Bio-Rad Laboratories, Inc.
    • Illumina, Inc.
    • MolecularMD
    • Invivoscribe, Inc.
    • Asuragen, Inc
    • Adaptive Biotechnologies
    • Future Impact
    • About Us
    • Contact

List of Tables

TABLE List of data sources

TABLE Market drivers; Impact Analysis

TABLE Market restraints; Impact Analysis

TABLE Global Hemato Oncology Testing Market: Type Snapshot (2019)

TABLE Segment Dashboard; Definition and Scope, By Service & Product

TABLE Global Hemato Oncology Testing Market, By Service & Product 2019-2029 (USD Million)

TABLE Hemato Oncology Testing Market: Caner Type Snapshot (2019)

TABLE Segment Dashboard; Definition and Scope, By Technology

TABLE Global Hemato Oncology Testing Market, By Technology 2019-2029 (USD Million)

TABLE Global Hemato Oncology Testing Market: Regional snapshot (2019)

TABLE Segment Dashboard; Definition and Scope, by Region

TABLE Global Hemato Oncology Testing Market, by Region 2019-2029 (USD Million)

TABLE North America Hemato Oncology Testing Market, by Country, 2019-2029 (USD Million)

TABLE North America Hemato Oncology Testing Market, By Service & Product, 2019-2029 (USD Million)

TABLE North America Hemato Oncology Testing Market, By Technology, 2019-2029 (USD Million)

TABLE Europe Hemato Oncology Testing Market, by Country, 2019-2029 (USD Million)

TABLE Europe Hemato Oncology Testing Market, By Service & Product, 2019-2029 (USD Million)

TABLE Europe Hemato Oncology Testing Market, By Technology, 2019-2029 (USD Million)

TABLE Asia Pacific Hemato Oncology Testing Market, by Country, 2019-2029 (USD Million)

TABLE Asia Pacific Hemato Oncology Testing Market, By Service & Product, 2019-2029 (USD Million)

TABLE Asia Pacific Hemato Oncology Testing Market, By Technology, 2019-2029 (USD Million)

TABLE Latin America Hemato Oncology Testing Market, by Country, 2019-2029 (USD Million)

TABLE Latin America Hemato Oncology Testing Market, by Product Type, 2019-2029 (USD Million)

TABLE Latin America Hemato Oncology Testing Market, By Technology, 2019-2029 (USD Million)

TABLE Middle East and Africa Hemato Oncology Testing Market, by Country, 2019-2029 (USD Million)

TABLE Middle East and Africa Hemato Oncology Testing Market, by Product Type, 2019-2029 (USD Million)

TABLE Middle East and Africa Hemato Oncology Testing Market, By Technology, 2019-2029 (USD Million)

 

 

List of Figures

FIGURE Hemato Oncology Testing Market Segmentation

FIGURE Market research methodology

FIGURE Value chain analysis

FIGURE Porter’s Five Forces Analysis

FIGURE Market Attractiveness Analysis

FIGURE COVID-19 Impact Analysis

FIGURE Pre & Post COVID-19 Impact Comparison Study

FIGURE Competitive Landscape; Key company market share analysis, 2019

FIGURE Product Type segment market share analysis, 2019 & 2029

FIGURE Product Type segment market size forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE Caner Type segment market share analysis, 2019 & 2029

FIGURE Caner Type segment market size forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE Regional segment market share analysis, 2019 & 2029

FIGURE Regional segment market size forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE North America Hemato Oncology Testing Market share and leading players, 2019

FIGURE Europe Hemato Oncology Testing Market share and leading players, 2019

FIGURE Asia Pacific Hemato Oncology Testing Market share and leading players, 2019

FIGURE Latin America Hemato Oncology Testing Market share and leading players, 2019

FIGURE Middle East and Africa Hemato Oncology Testing Market share and leading players, 2019

FIGURE North America market share analysis by country, 2019

FIGURE U.S. Hemato Oncology Testing Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE Canada Hemato Oncology Testing Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE Europe Hemato Oncology Testing Market share analysis by country, 2019

FIGURE Germany Hemato Oncology Testing Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE Spain Hemato Oncology Testing Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE Italy Hemato Oncology Testing Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE UK Hemato Oncology Testing Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE France Hemato Oncology Testing Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE Rest of the Europe Hemato Oncology Testing Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE Asia Pacific Hemato Oncology Testing Market share analysis by country, 2019

FIGURE India Hemato Oncology Testing Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE China Hemato Oncology Testing Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE Japan Hemato Oncology Testing Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE South Korea Hemato Oncology Testing Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE Rest of APAC Hemato Oncology Testing Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE Latin America Hemato Oncology Testing Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE Latin America Hemato Oncology Testing Market share analysis by country, 2019

FIGURE Brazil Hemato Oncology Testing Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE Mexico Hemato Oncology Testing Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE Argentina Hemato Oncology Testing Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE Rest of LATAM Hemato Oncology Testing Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE Middle East and Africa Hemato Oncology Testing Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE Middle East and Africa Hemato Oncology Testing Market share analysis by country, 2019

FIGURE Saudi Arabia Hemato Oncology Testing Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE United Arab Emirates Hemato Oncology Testing Market size, forecast and trend analysis, 2019 to 2029 (USD Million)

FIGURE Rest of Middle East and Africa Hemato Oncology Testing Market size, forecast and trend analysis, 2019 to 2029 (USD Million)